Vineet Laboratories Limited

NSE VINEETLAB.NS

Vineet Laboratories Limited Operating Income Margin for the year ending March 31, 2024: 3.11%

Vineet Laboratories Limited Operating Income Margin is 3.11% for the year ending March 31, 2024, a 21.98% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Vineet Laboratories Limited Operating Income Margin for the year ending March 31, 2023 was 2.55%, a -56.61% change year over year.
Vineet Laboratories Limited Operating Income Margin for the year ending March 31, 2022 was 5.87%, a 133.91% change year over year.
Vineet Laboratories Limited Operating Income Margin for the year ending March 31, 2021 was 2.51%.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

NSE: VINEETLAB.NS

Vineet Laboratories Limited

CEO	Mr. Gaddam Venkata Ramana
IPO Date	June 15, 2021
Location	India
Headquarters	5-5-160, Malleswari Nilayam
Employees	79
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Clinical Trials Composite Materials Cosmetics Personal Care Petrochemicals Plastics

Description

Vineet Laboratories Limited engages in the research, development, and manufacture of active pharmaceutical ingredients and fine chemicals in India. The company was incorporated in 2016 and is based in Hyderabad, India.

Key trends

Past 5 years